Rosacea Treatment Monitoring with Reflectance Confocal Microscopy, 20 Patients

A clinical study of 20 rosacea patients monitored before, during, and after a 16-week topical ivermectin treatment. Jade G. M. Logger collected reflectance confocal microscopy (RCM) data on mite counts, inflammatory cells, epidermal thickness, and vascular parameters. The dataset correlates these RCM features with clinical assessments of lesion reduction.

Use Cases

• Correlating clinical lesion scores with microscopic mite counts based on RCM measurements mentioned in the description
• Analyzing changes in Demodex mite presence over a treatment timeline based on the reported baseline, week 16, and week 28 detection rates
• Evaluating the utility of vascular density and diameter as non-invasive biomarkers for rosacea based on the described RCM parameters
• Assessing the predictive value of inflammatory cell counts for clinical success based on the study's correlation analysis

Strengths

• Longitudinal data with measurements taken at three time points: baseline, during treatment, and 12 weeks post-treatment
• Includes multiple quantitative RCM parameters: mite count, inflammatory cell count, epidermal thickness, vascular density, and vascular diameter
• Clinical correlation performed between RCM features and inflammatory lesion assessment

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The study's authors concluded RCM had limited value for non-invasive follow-up in its current form due to device limitations

Provenance

Source

Jade G. M. Logger via paperswithcode

Collection Method

Clinical trial involving reflectance confocal microscopy examinations of patients

Time Range

Covers a 28-week observation period (16-week treatment + 12-week follow-up)